Categories: industry/commercial news releases

6/20/2017

Study doesn’t back claims about radiation in elderly lung cancer patients

5/18/2017

Test for opioid abuse risk based on problematic evidence

5/10/2017

ALS drug announcement answers many questions but raises others about cost, benefits and a potential conflict of interest

5/3/2017

‘Aspirin can lower risk of breast cancer’ – No mention that this was an observational study

5/1/2017

Claims aplenty despite lack of demonstrated clinical benefit from Allergan’s new device for dry eyes

4/11/2017

Allergan announcement on botox for depression obscures negative results

2/14/2017

On Amgen’s heels, Bayer follows with data-free release touting ‘overwhelming’ benefit

2/7/2017

Take our word for it? Amgen declines to provide study results after sending glowing PR release on Repatha

1/11/2017

Release on new dry eye drug leaves readers high and dry

2 1/6/2017

Fish oil trade group inflates findings on heart disease risk reduction